← All companies
NovoCure Ltd
NVCR - CIK 0001645113
Market cap$1.94 B
Rank#2114
SEC filings1,138
The table below shows NovoCure Ltd's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $93.55M | $163.77M | $240.82M | $115.33M | $208.80M | $234.67M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $89.44M | $74.23M | $61.22M | $86.26M | $93.57M | $96.70M |
| Inventory | $41.11M | $35.09M | $38.15M | $29.38M | $24.43M | $27.42M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.